Catalyst Pharmaceutical
CPRX
CPRX
248 hedge funds and large institutions have $1.11B invested in Catalyst Pharmaceutical in 2023 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 83 increasing their positions, 83 reducing their positions, and 46 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
248
Holders Change
-11
Holders Change %
-4.25%
% of All Funds
3.91%
Holding in Top 10
3
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-50%
% of All Funds
0.05%
New
37
Increased
83
Reduced
83
Closed
46
Calls
$4.23M
Puts
$1.32M
Net Calls
+$2.91M
Net Calls Change
-$38.3M
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
$127M |
| 2 |
Man Group
London,
United Kingdom
|
$11.2M |
| 3 |
BlackRock
New York
|
$213M |
| 4 |
Barclays
London,
United Kingdom
|
$8.91M |
| 5 |
RA
Royce & Associates
New York
|
$14M |
Top Sellers
| 1 |
DM
Deerfield Management
New York
|
$110M |
| 2 |
Two Sigma Investments
New York
|
$341K |
| 3 |
Millennium Management
New York
|
$4.23M |
| 4 |
Two Sigma Advisers
New York
|
$8.51M |
| 5 |
JAM
Jupiter Asset Management
London,
United Kingdom
|
$7.34M |
